The first hearing concerning the consolidated Actos bladder cancer lawsuits has been scheduled by the presiding judge for March 22, 2012 in Louisiana. This first hearing is a status hearing where both sides will present to the court their case status as well as discuss possibilities for any potential Actos lawsuit settlement.
While the potential for substantive settlement discussions at this point is remote, the 150 Actos lawsuits consolidated in the U.S. District Court, for the Western District of Louisiana will be an important first step in the trial process.
The Actos bladder cancer lawsuits have named Takeda Pharmaceuticals, the manufacturer of Actos, as the defendant in the consolidated litigation.